Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease

The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associ...

Full description

Saved in:
Bibliographic Details
Main Authors BENNETT, FRANK, HUANG, YUHUA, ARASAPPAN, ASHOK, VENKATRAMAN, SRIKANTH, LOVEY, RAYMOND G, LIU, YI-TSUNG, HENDRATA, SISKA, GIRIJAVALLABHAN, VIYYOOR M, SAKSENA, ANIL K, BOGEN, STEPHANE L, CHEN, KEVIN X, SANNIGRAHI, MOUSUMI, NAIR, LATHA, NJOROGE, F. GEORGE, VELAZQUEZ, FRANCISCO
Format Patent
LanguageChinese
English
Published 21.04.2013
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
Bibliography:Application Number: TW200998107879